Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$168.31
1.290.77%
À la fermeture: -
$168.20
-0.11-0.07%
Après les heures de négociation: 7:59 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
NVIDIA Corp a un objectif de cours consensus de $209.57, basé sur les évaluations des 37 analystes. Le plus élevé est de $250 attribué par Loop Capital le juin 25, 2025, et le plus bas est de $100 attribué par Seaport Global le avril 30, 2025. Les 3 dernières évaluations d'analystes ont été publiées par Citigroup, JP Morgan et Citigroup le septembre 8, 2025, septembre 4, 2025 et août 28, 2025. Avec un objectif de cours moyen de $208.33 entre Citigroup, JP Morgan et Citigroup, il y a une variation implicite de 23.86% upside pour NVIDIA Corp à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Citigroup
JP Morgan
DA Davidson
Goldman Sachs
Craig-Hallum
1calculé à partir des notes des analystes
Notes d'analystes pour NVIDIA
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
09/08/2025 | 18.91% | Citigroup | $210 → $200 | Maintains | Buy | |||
09/04/2025 | 27.82% | JP Morgan | $215 → $215 | Maintains | Overweight | |||
08/28/2025 | 24.85% | Citigroup | $190 → $210 | Maintains | Buy | |||
08/28/2025 | 27.82% | JP Morgan | $170 → $215 | Maintains | Overweight | |||
08/28/2025 | 15.93% | DA Davidson | $135 → $195 | Maintains | Neutral | |||
08/28/2025 | 18.91% | Goldman Sachs | $200 → $200 | Reiterates | Buy → Buy | |||
08/28/2025 | 45.66% | Craig-Hallum | $195 → $245 | Maintains | Buy | |||
08/28/2025 | 33.77% | Oppenheimer | $200 → $225 | Maintains | Outperform | |||
08/28/2025 | 24.85% | Morgan Stanley | $206 → $210 | Maintains | Overweight | |||
08/28/2025 | 39.71% | B of A Securities | $220 → $235 | Maintains | Buy | |||
08/28/2025 | 24.85% | Wedbush | $210 → $210 | Reiterates | Outperform → Outperform | |||
08/28/2025 | 35.55% | Truist Securities | $210 → $228 | Maintains | Buy | |||
08/28/2025 | 42.69% | Cantor Fitzgerald | $240 → $240 | Reiterates | Overweight → Overweight | |||
08/28/2025 | 36.74% | Keybanc | $215 → $230 | Maintains | Overweight | |||
08/28/2025 | 33.77% | Bernstein | $185 → $225 | Maintains | Outperform | |||
08/28/2025 | 27.82% | Rosenblatt | $200 → $215 | Maintains | Buy | |||
08/28/2025 | 30.8% | Benchmark | $190 → $220 | Maintains | Buy | |||
08/28/2025 | 18.91% | Needham | $200 → $200 | Reiterates | Buy → Buy | |||
08/25/2025 | 26.04% | Stifel | $202 → $212 | Maintains | Buy | |||
08/25/2025 | 33.77% | Baird | $195 → $225 | Maintains | Outperform | |||
08/22/2025 | 27.23% | Evercore ISI Group | $190 → $214 | Maintains | Outperform | |||
08/21/2025 | 21.88% | UBS | $175 → $205 | Maintains | Buy | |||
08/21/2025 | 24.85% | Wedbush | $175 → $210 | Maintains | Outperform | |||
08/20/2025 | 27.82% | Keybanc | $190 → $215 | Maintains | Overweight | |||
08/19/2025 | 39.71% | TD Cowen | $140 → $235 | Maintains | Buy | |||
08/18/2025 | 42.69% | Cantor Fitzgerald | $200 → $240 | Maintains | Overweight | |||
08/18/2025 | 22.47% | Morgan Stanley | $200 → $206 | Maintains | Overweight | |||
08/14/2025 | 21.88% | Mizuho | $192 → $205 | Maintains | Outperform | |||
08/13/2025 | 33.77% | Piper Sandler | $180 → $225 | Maintains | Overweight | |||
08/11/2025 | 30.8% | Wells Fargo | $185 → $220 | Maintains | Overweight | |||
08/07/2025 | 18.91% | Goldman Sachs | $185 → $200 | Maintains | Buy | |||
08/04/2025 | 30.8% | B of A Securities | $220 → $220 | Reiterates | Buy → Buy | |||
07/30/2025 | 18.91% | Morgan Stanley | $170 → $200 | Maintains | Overweight | |||
07/16/2025 | 14.15% | Mizuho | $185 → $192 | Maintains | Outperform | |||
07/16/2025 | 18.91% | Needham | $160 → $200 | Maintains | Buy | |||
07/15/2025 | 15.93% | DZ Bank | $160 → $195 | Maintains | Buy | |||
07/15/2025 | 39.71% | Melius Research | $205 → $235 | Maintains | Buy | |||
07/15/2025 | 18.91% | Oppenheimer | $175 → $200 | Maintains | Outperform | |||
07/10/2025 | 9.99% | Goldman Sachs | → $185 | Initiates | → Buy | |||
07/07/2025 | 12.96% | Citigroup | $180 → $190 | Maintains | Buy | |||
07/03/2025 | 9.99% | Mizuho | $170 → $185 | Maintains | Outperform | |||
06/25/2025 | 48.63% | Loop Capital | $175 → $250 | Maintains | Buy | |||
06/17/2025 | 18.91% | Barclays | $170 → $200 | Maintains | Overweight | |||
06/16/2025 | 4.04% | Oppenheimer | $175 → $175 | Reiterates | Outperform → Outperform | |||
05/29/2025 | 24.85% | Truist Securities | $205 → $210 | Maintains | Buy | |||
05/29/2025 | -1.9% | Raymond James | $150 → $165 | Maintains | Strong Buy | |||
05/29/2025 | 7.02% | Piper Sandler | $150 → $180 | Maintains | Overweight | |||
05/29/2025 | 1.07% | Mizuho | $168 → $170 | Maintains | Outperform | |||
05/29/2025 | 7.02% | Citigroup | $150 → $180 | Maintains | Buy | |||
05/29/2025 | 1.07% | Morgan Stanley | $160 → $170 | Maintains | Overweight | |||
05/29/2025 | 1.07% | Barclays | $155 → $170 | Maintains | Overweight | |||
05/29/2025 | -19.74% | DA Davidson | $120 → $135 | Maintains | Neutral | |||
05/29/2025 | 18.91% | Rosenblatt | $178 → $200 | Maintains | Buy | |||
05/29/2025 | 12.96% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
05/29/2025 | -4.88% | Needham | $160 → $160 | Reiterates | Buy → Buy | |||
05/22/2025 | 4.04% | Wedbush | $175 → $175 | Reiterates | Outperform → Outperform | |||
05/14/2025 | -4.88% | B of A Securities | $150 → $160 | Maintains | Buy | |||
05/12/2025 | 4.04% | UBS | $180 → $175 | Maintains | Buy | |||
04/30/2025 | -40.55% | Seaport Global | → $100 | Initiates | → Sell | |||
04/25/2025 | -4.88% | Morgan Stanley | $162 → $160 | Maintains | Overweight | |||
04/23/2025 | 5.83% | Rosenblatt | $200 → $178 | Maintains | Buy | |||
04/22/2025 | -7.85% | Barclays | $175 → $155 | Maintains | Overweight | |||
04/17/2025 | 7.02% | UBS | $185 → $180 | Maintains | Buy | |||
04/16/2025 | 12.96% | Evercore ISI Group | $190 → $190 | Reiterates | Outperform → Outperform | |||
04/16/2025 | 18.91% | Rosenblatt | $220 → $200 | Maintains | Buy | |||
04/16/2025 | -28.66% | DA Davidson | $120 → $120 | Maintains | Neutral | |||
04/16/2025 | -10.82% | Raymond James | $170 → $150 | Maintains | Strong Buy | |||
04/16/2025 | 18.91% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
04/16/2025 | -10.82% | Piper Sandler | $175 → $150 | Maintains | Overweight | |||
04/16/2025 | 4.04% | Wedbush | $175 → $175 | Reiterates | Outperform → Outperform | |||
04/16/2025 | -4.88% | B of A Securities | $200 → $160 | Maintains | Buy | |||
04/14/2025 | -28.66% | DA Davidson | $125 → $120 | Maintains | Neutral | |||
04/11/2025 | -10.82% | Citigroup | $163 → $150 | Maintains | Buy | |||
04/09/2025 | -16.77% | TD Cowen | $175 → $140 | Maintains | Buy | |||
03/20/2025 | -25.68% | DA Davidson | $135 → $125 | Maintains | Neutral | |||
03/20/2025 | 12.96% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
03/19/2025 | 7.02% | Susquehanna | $180 → $180 | Maintains | Positive | |||
03/19/2025 | 18.91% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
03/19/2025 | — | Keybanc | — | Reiterates | Overweight → Overweight | |||
03/19/2025 | 18.91% | B of A Securities | $200 → $200 | Reiterates | Buy → Buy | |||
03/19/2025 | -4.88% | Needham | $160 → $160 | Reiterates | Buy → Buy | |||
03/19/2025 | 30.8% | Rosenblatt | $220 → $220 | Maintains | Buy | |||
03/19/2025 | 12.96% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
03/14/2025 | -0.12% | Mizuho | $175 → $168 | Maintains | Outperform | |||
02/27/2025 | -19.74% | DA Davidson | $135 → $135 | Maintains | Neutral | |||
02/27/2025 | 18.91% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
02/27/2025 | 12.96% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
02/27/2025 | 21.88% | Truist Securities | $204 → $205 | Maintains | Buy | |||
02/27/2025 | -3.69% | Morgan Stanley | $152 → $162 | Maintains | Overweight | |||
02/27/2025 | 18.91% | B of A Securities | $190 → $200 | Maintains | Buy | |||
02/27/2025 | -4.88% | Needham | $160 → $160 | Reiterates | Buy → Buy | |||
02/27/2025 | 30.8% | Rosenblatt | $220 → $220 | Maintains | Buy | |||
02/25/2025 | 12.96% | Evercore ISI Group | $190 → $190 | Reiterates | Outperform → Outperform | |||
02/24/2025 | 30.8% | Rosenblatt | $220 → $220 | Maintains | Buy | |||
02/20/2025 | 12.96% | Keybanc | $180 → $190 | Maintains | Overweight | |||
02/20/2025 | 15.93% | Baird | $195 → $195 | Reiterates | Outperform → Outperform | |||
01/28/2025 | -9.63% | Morgan Stanley | $166 → $152 | Maintains | Overweight | |||
01/28/2025 | 30.8% | Tigress Financial | $170 → $220 | Upgrade | Buy → Strong Buy | |||
01/27/2025 | 18.91% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
01/17/2025 | 4.04% | Barclays | $160 → $175 | Maintains | Overweight |
FAQ
Quel est le cours indicatif de l'action NVIDIA (NVDA) ?
Le dernier objectif de prix pour NVIDIA (NASDAQ:NVDA) a été rapporté par Citigroup le septembre 8, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $200.00 s'attendant à ce que NVDA se rise dans les 12 prochains mois (un possible changement de 18.91% upside). 100 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour NVIDIA (NVDA) ?
La dernière note d'analyste pour NVIDIA (NASDAQ:NVDA) a été fournie par Citigroup, et NVIDIA maintenu leur note buy.
Quand a eu lieu la dernière mise à niveau pour NVIDIA (NVDA) ?
La dernière amélioration pour NVIDIA Corp a eu lieu le janvier 28, 2025 lorsque Tigress Financial a augmenté leur objectif de prix à $220. Tigress Financial avait précédemment a buy pour NVIDIA Corp.
Quand a eu lieu la dernière dégradation pour NVIDIA (NVDA) ?
Il n'y a pas de dernière réduction pour NVIDIA.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour NVIDIA (NVDA) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de NVIDIA, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour NVIDIA a été déposée le septembre 8, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers septembre 8, 2026.
La note d'analyste pour NVIDIA (NVDA) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de NVIDIA (NVDA) était un maintenu avec un objectif de prix de $210.00 à $200.00. Le prix actuel de NVIDIA (NVDA) est de $168.20, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.